×
About 118,825 results

ALLMedicine™ Prostate Cancer Center

Research & Reviews  37,205 results

Referral to radiation oncology prior to prostatectomy: Referral rates in a New Zealand ...
https://doi.org/10.1111/1754-9485.13446
Journal of Medical Imaging and Radiation Oncology; Xu-Holland AC, Kain M

Jun 26th, 2022 - Radical prostatectomy and radical radiotherapy have equivalent survival outcomes in the treatment of localised prostate cancer but differing side-effect profiles. The 2018 Faculty of Radiation Oncology of the Royal Australasian College of Radiolog...

Early prediction of prostate cancer risk in younger men using polygenic risk scores and...
https://doi.org/10.1002/cam4.4934
Cancer Medicine; Varma A, Maharjan J et. al.

Jun 26th, 2022 - Prostate cancer (PCa) screening is not routinely conducted in men aged 55 and younger, although this age group accounts for more than 10% of cases. Polygenic risk scores (PRSs) and patient data applied toward early prediction of PCa may lead to ea...

Definitive treatment choice among Black immigrants with prostate cancer: Analysis of pa...
https://doi.org/10.1002/pros.24399
The Prostate; Heard JR, Huang AJ et. al.

Jun 25th, 2022 - Large-scale prostate cancer (PCa) database reviews have found a consistent discrepancy in the mortality rate in Black patients compared to their White counterparts. Furthermore, differences in PCa treatment and outcomes among Black men of differen...

Serum prolactin level as a predictive factor for abiraterone response in patients with ...
https://doi.org/10.1002/pros.24402
The Prostate; Yang T, Liu Y et. al.

Jun 25th, 2022 - To investigate the prognostic value and potential therapeutic target of the baseline serum hormones in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone. This retrospective study was performed in patien...

see more →

Guidelines  81 results

ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate ...
https://doi.org/10.1097/COC.0000000000000915
American Journal of Clinical Oncology; Bittner NHJ, Cox BW et. al.

May 20th, 2022 - The American College of Radiology (ACR), American Brachytherapy Society (ABS), and American Society for Radiation Oncology (ASTRO) have jointly developed the following practice parameter for transperineal permanent brachytherapy of prostate cancer...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radi...
https://doi.org/10.1097/JU.0000000000002759
The Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 11th, 2022 - The summary presented herein represents Part III of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of radiation and offering several future directions of further relevant study i...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Activ...
https://doi.org/10.1097/JU.0000000000002758
The Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 11th, 2022 - The summary presented herein represents Part II of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of active surveillance and surgery as well as follow-up for patients after prima...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk A...
https://doi.org/10.1097/JU.0000000000002757
The Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 11th, 2022 - The summary presented herein represents Part I of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment, staging, and risk-based management in patients diagnosed with clinically lo...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Endorsed by SUO
https://www.auanet.org/guidelines/guidelines/clinically-localized-prostate-cancer-aua/astro-guideline-2022
Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 10th, 2022 - The recommendations discussed herein for the management of clinically localized prostate cancer provide a framework stratified by risk to facilitate care decisions and guide clinicians in the implementation of selected management options.

see more →

Drugs  212 results see all →

Clinicaltrials.gov  4,866 results

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT02769962

Jun 24th, 2022 - Background: Small cell lung cancer (SCLC) is an aggressive cancer with a poor prognosis. Although highly responsive to chemotherapy initially, SCLC relapses quickly and becomes refractory to treatment within a few months. Urothelial Carcinoma (UC)...

Fusion Guided Focal Laser Ablation of Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT02759744

Jun 24th, 2022 - Background: Pilot study to evaluate the feasibility of real time ultrasound imaging to guide focal thermal ablation of low risk focal prostate tumors Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 t...

Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
https://clinicaltrials.gov/ct2/show/NCT04541030

Jun 24th, 2022 - Background: Prostate cancer is one of the most common malignancies occurring in men. While many men will qualify for active surveillance (AS), those with intermediate risk disease are often recommended definitive therapy despite the morbidity. Foc...

The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
https://clinicaltrials.gov/ct2/show/NCT03436745

Jun 24th, 2022 - Background: Zolpidem is currently approved for the treatment of patients with insomnia. Women reported experiencing an increased incidence of adverse effects than men, resulting in a reduction of the recommended dose of zolpidem for women. Zolpide...

Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT01867333

Jun 24th, 2022 - Background: Enzalutamide is a well-tolerated, modern androgen receptor antagonist (ARA) with more enhanced anti-tumor activity compared to previous ARAs. Phase III trial has demonstrated a 4.8 month improvement in survival and a 37% risk reduction...

see more →

News  5,094 results

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://reference.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://www.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Focused Ultrasound Controls Prostate Cancer With Fewer Side Effects
https://www.medscape.com/viewarticle/975716

Jun 17th, 2022 - NEW YORK (Reuters Health) - MRI-guided focused ultrasound (MRgFUS) continues to show promise in men with intermediate-risk prostate cancer, with effective disease control and fewer side effects relative to other treatments, according to new resear...

Active Treatment or Observation for Localized Prostate Cancer?
https://www.medscape.com/viewarticle/975848

Jun 17th, 2022 - This study was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Compared with observation, active treatment lowers the risk for overall and prostate cancer-specific death in men with localized prostate...

New Advances Transform Treatment of Prostate Cancer
https://www.medscape.com/viewarticle/975379

Jun 10th, 2022 - The way we treat prostate cancer has changed dramatically in recent years. Advances in MRI imaging have undoubtedly contributed to this change, both in terms of diagnosis — by making targeted biopsies possible — and in terms of our approach to tre...

see more →

Patient Education  72 results see all →